Definitive Healthcare Q1 adjusted net income rises 22% to $8.5 million; revenue falls 6% to $55.9 million

• Definitive Healthcare Q1 2026 revenue fell 6% to 55.9 million, while adjusted EBITDA rose 4% to 15.3 million.
• Adjusted EBITDA margin widened 2.6 percentage points to 27%, with management citing broader expense efficiency, higher capitalized software spend, and a timing gap of a new data source.
• Unlevered free cash flow dropped 22% to 18 million, while cash flow from operations slid 56% to 11.6 million.
• Full-year revenue outlook was maintained at 220 million-226 million, while adjusted EBITDA guidance increased to 55 million-59 million; CEO Kevin Coop said early indications of progress include improved retention rates.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Definitive Healthcare Corp. published the original content used to generate this news brief on May 07, 2026, and is solely responsible for the information contained therein.